- CURE will present at the LD 500 Virtual Conference, September 4 at 8:20 am PDT -
- CURE CEO will be a panelist at the 4@4 Forum on September 10 @4pm PDT
OXNARD, Calif., Sept. 02, 2020 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced that it will be presenting at two upcoming virtual conferences in September.
The LD 500 Virtual Conference on Friday, September 4 at 8:20amPDT/11:20pm EDT
Rob Davidson, President and CEO of CURE Pharmaceutical will present to a live virtual audience at the LD 500 investor conference on Friday, September 4 at 8:20am PDT. The LD 500 will take place on September 1-4. Register here: https://ld500.ldmicro.com/
The full conference profile for CURE Pharmaceutical Holdings can be viewed here: https://www.ldmicro.com/profile/CURR.
Four At Four Forum on September 10 @ 4pm PDT
Rob Davidson will be joined by Nancy Duitch, CEO of Sera Labs as featured panelists at the Virtual 4@4 Forum on September 10 at 4pm PDT. The topic for the event is “CBD, Cannabis and the Cannabiz”. Registration is free but is required in advance at: https://4at4cannabiz.eventbrite.com